Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sandi See Tai"'
Autor:
Marianna Bruno, Daniel P. Judge, Sandi See Tai, Jeffery W. Kelly, Marla B. Sultan, Steve Riley, Adam Castaño, Arianna Burton, Jennifer Schumacher, Jignesh Patel
Publikováno v:
Drug Design, Development and Therapy
Rare diseases are increasingly recognized as a global public health priority. Governments worldwide currently provide important incentives to stimulate the discovery and development of orphan drugs for the treatment of these conditions, but substanti
Publikováno v:
Journal of the American College of Cardiology. 81:336
Autor:
Steve Riley, Marla B. Sultan, Denis Keohane, Balarama Gundapaneni, Jennifer Schumacher, Sandi See Tai
Publikováno v:
Canadian Journal of Cardiology. 37:S65
BACKGROUND Transthyretin amyloid cardiomyopathy (ATTR-CM) is a fatal disease caused by destabilization of the transthyretin (TTR) tetramer resulting in the formation of amyloid fibrils that deposit in the heart, leading to heart failure and ultimatel
Autor:
Debra Sierka, Joan M. Korth-Bradley, Didier A. Mandelbrot, Daniel I. Levy, Michael A. Tortorici, David W. Holt, Sandi See Tai, Gary L. Horowitz
Publikováno v:
Clinical Transplantation. 28:243-251
Results of therapeutic monitoring of sirolimus blood concentrations are assay and laboratory dependent. This study compared performance over time of the IMx microparticle enzyme immunoassay (MEIA), Architect chemiluminescent microparticle immunoassay
Autor:
Graeme R. Russ, Seth Schulman, Stuart M. Flechner, Christophe Legendre, Huihua Li, C. Hahn, Josep M. Campistol, Alihan Gurkan, Anders Hartmann, Francesco Paolo Schena, Joan M. Korth-Bradley, Sandi See Tai
Publikováno v:
Transplantation. 95:1233-1241
BACKGROUND Despite a decreased incidence of acute rejection and early renal allograft loss due to calcineurin inhibitors (CNIs) in transplant recipients, nephrotoxicity associated with long-term CNI use remains an important issue. This study evaluate